Drugs / Insulin Degludec/Liraglutide
last change Apr 2022 re-read 3 minutes ago

Insulin Degludec/Liraglutide

Developed for
type 2 diabetes mellitus
Investigated by
University of Palermo

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05360537 Apr → Dec 2021 type 2 diabetes mellitus University of Palermo Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Insulin Degludec/Liraglutide “administration of Insulin Degludec/Liraglutide” NCT05360537 ↗